Gout in systemic lupus erythematosus and overlap syndrome - a hospital-based study

被引:8
作者
Ho, HH [1 ]
Lin, JL [1 ]
Wu, YJJ [1 ]
Yu, KH [1 ]
Chen, JY [1 ]
Luo, SF [1 ]
机构
[1] Chang Gung Mem Hosp, Div Rheumatol Allergy & Immunol, Tao Yuan, Taiwan
关键词
cardiovascular disorder; diuretics; gout; membranous glomerulonephritis; renal disorder; systemic lupus erythematosus;
D O I
10.1007/s10067-003-0735-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The negative association between gout and rheumatoid arthritis is widely accepted, and gout is also speculated to be rare in systemic lupus erythematosus (SLE), as only a few sporadic cases have been reported. From 1985 to 2001 we encountered 15 lupus patients at Chang-Gung Memorial Hospital, including two with lupus-scleroderma and one with lupus-scleroderma-polymyositis overlap syndrome coexisting with gout. This study retrospectively analyses the clinical and laboratory characteristics of these patients. A lower female predominance is found, and most patients developed gout after the onset of SLE, although gout preceded SLE in two cases. Measurement of serum uric acid and 24-h urine uric acid found all of the patients to be hyperuricaemic and underexcretors of uric acid. Furthermore, most of the patients (14/15) were receiving diuretics. Also, many had hypertension and serious cardiovascular diseases. Renal impairment during gouty attacks seemed to be a predisposing factor for developing end-stage renal disease. Gouty arthritis usually occurred during relative SLE inactivity, podagra was frequent, and tophi were found in a few patients. Compared with the unselected population of SLE patients, the cases studied here had a higher incidence of chronic arthritis, malar rash, haematologic disorder, photosensitivity, serositis and neurologic disorder. Renal disease in the patients sampled was frequently membranous nephropathy.
引用
收藏
页码:295 / 298
页数:4
相关论文
共 29 条
[1]   INHIBITION OF MACROPHAGE DIFFERENTIATION AND FUNCTION BY CORTISOL [J].
BAYBUTT, HN ;
HOLSBOER, F .
ENDOCRINOLOGY, 1990, 127 (01) :476-480
[2]  
BRADLEY JD, 1984, CLIN EXP RHEUMATOL, V2, P151
[3]  
Chang SJ, 1997, J RHEUMATOL, V24, P1364
[4]   SYSTEMIC LUPUS-ERYTHEMATOSUS IN PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
CHEIGH, JS ;
STENZEL, KH ;
RUBIN, AL ;
CHAMI, J ;
SULLIVAN, JF .
AMERICAN JOURNAL OF MEDICINE, 1983, 75 (04) :602-606
[5]  
Chou CT, 1998, BRIT J RHEUMATOL, V37, P258
[6]  
Chou Pesus, 1993, Journal of the Formosan Medical Association, V92, P597
[7]  
DURBACK MA, 1988, J RHEUMATOL, V15, P1503
[8]  
FROCHT A, 1987, BRIT J RHEUMATOL, V26, P303
[9]   STUDIES ON THE INTERACTION OF RHEUMATOID-FACTOR WITH MONOSODIUM URATE CRYSTALS AND CASE-REPORT OF COEXISTENT TOPHACEOUS GOUT AND RHEUMATOID-ARTHRITIS [J].
GORDON, TP ;
AHERN, MJ ;
REID, C ;
ROBERTSTHOMSON, PJ .
ANNALS OF THE RHEUMATIC DISEASES, 1985, 44 (06) :384-389
[10]   SYSTEMIC LUPUS-ERYTHEMATOSUS AND GOUT [J].
GREENFIELD, DI ;
FONG, JS ;
BARTH, WF .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1985, 14 (03) :176-179